Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-09

FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved the original application for a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, manufactured by Mylan Pharmac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)